NGN Capital is a venture capital firm dedicated to healthcare investing, focusing on ventures with the potential to achieve above-average private equity returns, with an emphasis on later-stage investments. The firm has the flexibility to invest across a broad spectrum of healthcare and biotechnology segments, including drug products, medical devices, and other healthcare services. Diversified by stage—from later-stage to selected early-stage opportunities—and by geography, NGN Capital predominantly invests in the U.S. and Europe.